{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T20:37:33Z","timestamp":1793047053723,"version":"4.5.0"},"reference-count":53,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T00:00:00Z","timestamp":1792627200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100016036","name":"Health~Holland","doi-asserted-by":"publisher","award":["LSHM18034"],"award-info":[{"award-number":["LSHM18034"]}],"id":[{"id":"10.13039\/100016036","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Autoimmunity"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.jaut.2026.103623","type":"journal-article","created":{"date-parts":[[2026,9,13]],"date-time":"2026-09-13T01:56:47Z","timestamp":1789264607000},"page":"103623","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Autoantibodies in systemic sclerosis display a proinflammatory Fc glycosylation signature independent of systemic inflammation"],"prefix":"10.1016","volume":"164","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5619-4508","authenticated-orcid":false,"given":"Wieke M.","family":"van Oostveen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdulellah M.","family":"Alzahrani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sam","family":"Neppelenbroek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.W. Nivine","family":"Levarht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Nouta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine E.","family":"van der Wouden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna M.","family":"Wasy\u0144czuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Falck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lise","family":"Hafkenscheid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeska K.","family":"de Vries-Bouwstra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manfred","family":"Wuhrer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ren\u00e9 E.M.","family":"Toes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cynthia M.","family":"Fehres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaut.2026.103623_bib1","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1093\/glycob\/cwz048","article-title":"Monitoring of immunoglobulin N- and O-glycosylation in health and disease","volume":"30","author":"de Haan","year":"2020","journal-title":"Glycobiology"},{"key":"10.1016\/j.jaut.2026.103623_bib2","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1146\/annurev.immunol.25.022106.141702","article-title":"The impact of glycosylation on the biological function and structure of human immunoglobulins","volume":"25","author":"Arnold","year":"2007","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.jaut.2026.103623_bib3","doi-asserted-by":"crossref","first-page":"26733","DOI":"10.1074\/jbc.M202069200","article-title":"Lack of fucose on human IgG1 N-linked oligosaccharide improves binding to human Fc\u03b3RIII and antibody-dependent cellular toxicity","volume":"277","author":"Shields","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jaut.2026.103623_bib4","doi-asserted-by":"crossref","first-page":"12669","DOI":"10.1073\/pnas.1108455108","article-title":"Unique carbohydrate-carbohydrate interactions are required for high affinity binding between FcgammaRIII and antibodies lacking core fucose","volume":"108","author":"Ferrara","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jaut.2026.103623_bib5","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.4049\/jimmunol.2100399","article-title":"Fc galactosylation promotes hexamerization of human IgG1, leading to enhanced classical complement activation","volume":"207","author":"van Osch","year":"2021","journal-title":"J. Immunol."},{"key":"10.1016\/j.jaut.2026.103623_bib6","doi-asserted-by":"crossref","first-page":"8433","DOI":"10.1073\/pnas.0702936104","article-title":"Agalactosylated IgG antibodies depend on cellular Fc receptors for in vivo activity","volume":"104","author":"Nimmerjahn","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jaut.2026.103623_bib7","doi-asserted-by":"crossref","first-page":"646","DOI":"10.3389\/fimmu.2017.00646","article-title":"Fc-Galactosylation of human immunoglobulin gamma isotypes improves C1q binding and enhances complement-dependent cytotoxicity","volume":"8","author":"Peschke","year":"2017","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jaut.2026.103623_bib8","doi-asserted-by":"crossref","DOI":"10.1126\/science.abc8378","article-title":"Afucosylated IgG characterizes enveloped viral responses and correlates with COVID-19 severity","volume":"371","author":"Larsen","year":"2021","journal-title":"Science"},{"key":"10.1016\/j.jaut.2026.103623_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2022.103957","article-title":"Immunoglobulin G1 Fc glycosylation as an early hallmark of severe COVID-19","volume":"78","author":"Pongracz","year":"2022","journal-title":"EBioMedicine"},{"key":"10.1016\/j.jaut.2026.103623_bib10","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1002\/art.27414","article-title":"Glycan profiling of anti-citrullinated protein antibodies isolated from human serum and synovial fluid","volume":"62","author":"Scherer","year":"2010","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jaut.2026.103623_bib11","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1136\/annrheumdis-2013-203565","article-title":"Anti-citrullinated protein antibodies acquire a pro-inflammatory Fc glycosylation phenotype prior to the onset of rheumatoid arthritis","volume":"74","author":"Rombouts","year":"2015","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jaut.2026.103623_bib12","doi-asserted-by":"crossref","first-page":"2978","DOI":"10.1002\/art.39273","article-title":"Association of systemic lupus erythematosus with decreased immunosuppressive potential of the IgG glycome","volume":"67","author":"Vu\u010dkov\u00efc","year":"2015","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.jaut.2026.103623_bib13","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1021\/pr500780a","article-title":"Skewed Fc glycosylation profiles of anti-proteinase 3 immunoglobulin G1 autoantibodies from granulomatosis with polyangiitis patients show low levels of bisection, galactosylation, and sialylation","volume":"14","author":"Wuhrer","year":"2015","journal-title":"J. Proteome Res."},{"key":"10.1016\/j.jaut.2026.103623_bib14","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.ebiom.2017.01.033","article-title":"Galactosylation and sialylation levels of IgG predict relapse in patients with PR3-ANCA associated vasculitis","volume":"17","author":"Kemna","year":"2017","journal-title":"EBioMedicine"},{"key":"10.1016\/j.jaut.2026.103623_bib15","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0213215","article-title":"Immunoglobulins G from patients with ANCA-associated vasculitis are atypically glycosylated in both the Fc and fab regions and the relation to disease activity","volume":"14","author":"Lardinois","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.jaut.2026.103623_bib16","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1046\/j.1365-2249.2002.01864.x","article-title":"Hypogalactosylation of serum IgG in patients with ANCA-associated systemic vasculitis","volume":"129","author":"Holland","year":"2002","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.jaut.2026.103623_bib17","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1002\/art.43018","article-title":"Impact of IgG Fc glycosylation on disease dynamics in patients with primary sj\u00f6gren disease","volume":"77","author":"Achten","year":"2025","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.jaut.2026.103623_bib18","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1053\/j.gastro.2018.01.002","article-title":"Glycosylation of Immunoglobulin G associates with clinical features of inflammatory bowel diseases","volume":"154","author":"Simurina","year":"2018","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jaut.2026.103623_bib19","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1016\/S0140-6736(17)30933-9","article-title":"Systemic sclerosis","volume":"390","author":"Denton","year":"2017","journal-title":"Lancet (London, England)"},{"key":"10.1016\/j.jaut.2026.103623_bib20","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1177\/23971983231175213","article-title":"Nailfold capillaroscopy and candidate-biomarker levels in systemic sclerosis-associated pulmonary hypertension: a cross-sectional study","volume":"8","author":"Lemmers","year":"2023","journal-title":"J. Scleroderma Relat. Disorders"},{"key":"10.1016\/j.jaut.2026.103623_bib21","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1093\/rheumatology\/keaa911","article-title":"Disease progression in systemic sclerosis","volume":"60","author":"van Leeuwen","year":"2021","journal-title":"Rheumatology"},{"key":"10.1016\/j.jaut.2026.103623_bib22","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2023-003148","article-title":"Anti-topoisomerase, but not anti-centromere B cell responses in systemic sclerosis display active, Ig-secreting cells associated with lung fibrosis","volume":"9","author":"Wortel","year":"2023","journal-title":"RMD Open"},{"key":"10.1016\/j.jaut.2026.103623_bib23","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1002\/art.41403","article-title":"Association of anti\u2013topoisomerase I antibodies of the IgM isotype with disease progression in anti\u2013topoisomerase I\u2013Positive systemic sclerosis","volume":"72","author":"Boonstra","year":"2020","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.jaut.2026.103623_bib24","doi-asserted-by":"crossref","first-page":"2338","DOI":"10.1002\/art.41814","article-title":"Anticentromere antibody levels and isotypes and the development of systemic sclerosis","volume":"73","author":"van Leeuwen","year":"2021","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.jaut.2026.103623_bib25","doi-asserted-by":"crossref","first-page":"402","DOI":"10.3899\/jrheum.191331","article-title":"Association between centromere- and topoisomerase-specific immune responses and the degree of microangiopathy in systemic sclerosis","volume":"48","author":"van Leeuwen","year":"2021","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.jaut.2026.103623_bib26","doi-asserted-by":"crossref","first-page":"2737","DOI":"10.1002\/art.38098","article-title":"2013 classification criteria for systemic sclerosis: an American college of rheumatology\/European league against rheumatism collaborative initiative","volume":"65","author":"Van Den Hoogen","year":"2013","journal-title":"Arthritis Rheum."},{"issue":"8","key":"10.1016\/j.jaut.2026.103623_bib27","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1016\/j.ard.2026.03.016","article-title":"Topoisomerase 1-DNA complexes are preferentially recognised by a subset of anti-topoisomerase 1 autoantibodies and their corresponding B cell receptors in systemic sclerosis","author":"Neppelenbroek","year":"2026","journal-title":"Ann. Rheum. Dis."},{"issue":"6","key":"10.1016\/j.jaut.2026.103623_bib28","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1038\/s41596-024-00963-7","article-title":"GlYcoLISA: antigen-specific and subclass-specific IgG Fc glycosylation analysis based on an immunosorbent assay with an LC\u2013MS readout","author":"Falck","year":"2024","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.jaut.2026.103623_bib29","doi-asserted-by":"crossref","first-page":"2198","DOI":"10.1021\/acs.jproteome.6b00171","article-title":"LaCyTools: a targeted liquid chromatography-mass spectrometry data processing package for relative quantitation of glycopeptides","volume":"15","author":"Jansen","year":"2016","journal-title":"J. Proteome Res."},{"key":"10.1016\/j.jaut.2026.103623_bib30","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1007\/s00216-025-05794-3","article-title":"GlycoDash: automated, visually assisted curation of glycoproteomics datasets for large sample numbers","volume":"417","author":"Pongracz","year":"2025","journal-title":"Anal. Bioanal. Chem."},{"issue":"D1","key":"10.1016\/j.jaut.2026.103623_bib31","doi-asserted-by":"crossref","first-page":"D543","DOI":"10.1093\/nar\/gkae1011","article-title":"The PRIDE database at 20 years: 2025 update","volume":"53","author":"Y","year":"2025","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.jaut.2026.103623_bib32","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/316452a0","article-title":"Association of rheumatoid arthritis and primary osteoarthritis with changes in the glycosylation pattern of total serum IgG","volume":"316","author":"Parekh","year":"1985","journal-title":"Nature"},{"key":"10.1016\/j.jaut.2026.103623_bib33","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1002\/art.1780310304","article-title":"Abnormal glycosylation of serum IgG from patients with chronic inflammatory diseases","volume":"31","author":"Tomana","year":"1988","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jaut.2026.103623_bib34","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/s002960050080","article-title":"Agalactosyl IgG is elevated in patients with active spondyloarthropathy","volume":"18","author":"Leirisalo-Repo","year":"1999","journal-title":"Rheumatol. Int."},{"key":"10.1016\/j.jaut.2026.103623_bib35","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1002\/prca.200800098","article-title":"Immunoglobulin 1 (IgG1) Fc-glycosylation profiling of anti-citrullinated peptide antibodies from human serum","volume":"3","author":"Scherer","year":"2009","journal-title":"Proteonomics Clin. Appl."},{"key":"10.1016\/j.jaut.2026.103623_bib36","doi-asserted-by":"crossref","first-page":"2239","DOI":"10.1002\/art.27533","article-title":"Aberrant IgG galactosylation precedes disease onset, correlates with disease activity, and is prevalent in autoantibodies in rheumatoid arthritis","volume":"62","author":"Ercan","year":"2010","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jaut.2026.103623_bib37","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1021\/pr1004373","article-title":"IgG fc N-glycosylation changes in Lambert-Eaton myasthenic syndrome and myasthenia gravis","volume":"10","author":"Selman","year":"2011","journal-title":"J. Proteome Res."},{"key":"10.1016\/j.jaut.2026.103623_bib38","first-page":"1237","article-title":"Inflammatory bowel disease associates with proinflammatory potential of the immunoglobulin G glycome","volume":"21","author":"Trbojevic Akmacic","year":"2015","journal-title":"Inflamm. Bowel Dis."},{"key":"10.1016\/j.jaut.2026.103623_bib39","doi-asserted-by":"crossref","DOI":"10.1038\/srep28207","article-title":"IgG1 Fc N-glycan galactosylation as a biomarker for immune activation","volume":"6","author":"de Jong","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jaut.2026.103623_bib40","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1136\/annrheumdis-2018-212946","article-title":"ACPA IgG galactosylation associates with disease activity in pregnant patients with rheumatoid arthritis","volume":"77","author":"Bondt","year":"2018","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jaut.2026.103623_bib41","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1016\/j.jaci.2020.04.059","article-title":"IgG Fc sialylation is regulated during the germinal center reaction following immunization with different adjuvants","volume":"146","author":"Bartsch","year":"2020","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.jaut.2026.103623_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2022.104408","article-title":"The BNT162b2 mRNA SARS-CoV-2 vaccine induces transient afucosylated IgG1 in naive but not in antigen-experienced vaccinees","volume":"87","author":"Van Coillie","year":"2023","journal-title":"EBioMedicine"},{"key":"10.1016\/j.jaut.2026.103623_bib43","doi-asserted-by":"crossref","DOI":"10.1074\/mcp.M110.004655","article-title":"Fc-glycosylation of IgG1 is modulated by B-cell stimuli","volume":"10","author":"Wang","year":"2011","journal-title":"Mol. Cell. Proteomics"},{"key":"10.1016\/j.jaut.2026.103623_bib44","article-title":"Cytokines in the immune microenvironment change the glycosylation of IgG by regulating intracellular glycosyltransferases","volume":"12","author":"Cao","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jaut.2026.103623_bib45","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-03196-w","article-title":"A functional spleen contributes to afucosylated IgG in humans","volume":"11","author":"Wojcik","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jaut.2026.103623_bib46","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1016\/S0140-6736(87)92621-3","article-title":"Reduced B-cell galactosyltransferase activity in rheumatoid arthritis","volume":"2","author":"Axford","year":"1987","journal-title":"Lancet"},{"key":"10.1016\/j.jaut.2026.103623_bib47","doi-asserted-by":"crossref","first-page":"6123","DOI":"10.1073\/pnas.91.13.6123","article-title":"Agalactosyl glycoforms of IgG autoantibodies are pathogenic","volume":"91","author":"Rademacher","year":"1994","journal-title":"Proc. Natl. Acad. Sci. USA."},{"key":"10.1016\/j.jaut.2026.103623_bib48","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1038\/nm.2862","article-title":"Anti-inflammatory activity of IgG1 mediated by Fc galactosylation and association of FcgammaRIIB and dectin-1","volume":"18","author":"Karsten","year":"2012","journal-title":"Nat. Med."},{"key":"10.1016\/j.jaut.2026.103623_bib49","doi-asserted-by":"crossref","first-page":"9868","DOI":"10.1073\/pnas.1307864110","article-title":"General mechanism for modulating immunoglobulin effector function","volume":"110","author":"Sondermann","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.jaut.2026.103623_bib50","doi-asserted-by":"crossref","first-page":"877","DOI":"10.3389\/fimmu.2017.00877","article-title":"Decoding the human Immunoglobulin G-Glycan repertoire reveals a spectrum of Fc-Receptor- and complement-mediated-effector activities","volume":"8","author":"Dekkers","year":"2017","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.jaut.2026.103623_bib51","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1038\/s41584-022-00867-4","article-title":"Glycobiology of rheumatic diseases","volume":"19","author":"Kissel","year":"2022","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.jaut.2026.103623_bib52","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1080\/19420862.2015.1045173","article-title":"Comparison of methods for the analysis of therapeutic immunoglobulin G Fc-glycosylation profiles-part 2: mass spectrometric methods","volume":"7","author":"Reusch","year":"2015","journal-title":"mAbs"},{"key":"10.1016\/j.jaut.2026.103623_bib53","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1093\/glycob\/cwac026","article-title":"Developments and perspectives in high-throughput protein glycomics: enabling the analysis of thousands of samples","volume":"32","author":"de Haan","year":"2022","journal-title":"Glycobiology"}],"container-title":["Journal of Autoimmunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0896841126001010?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0896841126001010?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T20:07:21Z","timestamp":1793045241000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0896841126001010"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":53,"alternative-id":["S0896841126001010"],"URL":"https:\/\/doi.org\/10.1016\/j.jaut.2026.103623","relation":{},"ISSN":["0896-8411"],"issn-type":[{"value":"0896-8411","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Autoantibodies in systemic sclerosis display a proinflammatory Fc glycosylation signature independent of systemic inflammation","name":"articletitle","label":"Article Title"},{"value":"Journal of Autoimmunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaut.2026.103623","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"103623"}}